Research Project
Grant-in-Aid for Young Scientists (B)
We previously reported that bortezomib induces cell death and increases chemosensitivity via transcriptional repression of Notch1 in T-cell acute lymphoblastic leukemia. The down-regulation of Notch1 was caused by the degradation of Sp1. But the mechanism of Sp1 degradation is still unknown. We hypothesized that Sp1 is degraded by some microRNA. In order to find the microRNA targeting Sp1, we performed the microRNA array and identified that miR-155 was up-regulated by bortezomib. We confirmed it using CRISPR/Cas9 system. These results indicated that miR-155 could be the biomarker of the drug sensitivity for bortezomib.
All 2015 Other
All Journal Article (3 results) (of which Int'l Joint Research: 1 results, Peer Reviewed: 3 results, Open Access: 2 results, Acknowledgement Compliant: 2 results) Remarks (2 results)
J Clin Invest
Volume: 125 Issue: 12 Pages: 4375-4390
10.1172/jci80325
Blood
Volume: 125 Issue: 24 Pages: 3731-3746
10.1182/blood-2014-11-610907
Biochem. Biophys. Res. Commun.
Volume: 467 Issue: 4 Pages: 1019-1025
10.1016/j.bbrc.2015.10.018
https://www.jichi.ac.jp/news/research/2015/20151124.html
http://www.jichi.ac.jp/openlab/newsletter/h46_spletter.pdf